Get startedLog in
    Picture of Novakand Pharma AB logo

    NOVKAN — Novakand Pharma AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Kancera Conducts Final Activities To Complete Phase Ib/IIa Study In Ovarian Cancer

    Picture of Novakand Pharma AB logoNovakand Pharma AB
    20/05/2025 07:33
    May 20 (Reuters) - Kancera AB KANC.ST:

CONDUCTS JOINT INVESTOR MEETINGS WITH RECARDIO INC.

EXPECTS FDA PRE-IND FEEDBACK ON PHASE IIB STUDY

CONDUCTING FINAL ACTIVITIES TO COMPLETE PHASE IB/IIA STUDY IN OVARIAN CANCER, TOP-LINE RESULTS EXPECTED TO BE PRESENTED DURING Q3

Source text: ID:nMFN9HJC8P

Further company coverage: KANC.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Novakand Pharma AB

    See all news